Cargando…

Phosphatidylethanolamine Induces an Antifibrotic Phenotype in Normal Human Lung Fibroblasts and Ameliorates Bleomycin-Induced Lung Fibrosis in Mice

Lung surfactant is a complex mixture of phospholipids and specific proteins but its role in the pathogenesis of interstitial lung diseases is not established. Herein, we analyzed the effects of three representative phospholipid components, that is, dipalmitoilphosphatidylcoline (DPPC), phosphatidylg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vazquez-de-Lara, Luis G., Tlatelpa-Romero, Beatriz, Romero, Yair, Fernández-Tamayo, Nora, Vazquez-de-Lara, Fernando, M. Justo-Janeiro, Jaime, Garcia-Carrasco, Mario, de-la-Rosa Paredes, René, Cisneros-Lira, José G., Mendoza-Milla, Criselda, Moccia, Francesco, Berra-Romani, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164566/ https://www.ncbi.nlm.nih.gov/pubmed/30223424 http://dx.doi.org/10.3390/ijms19092758

Ejemplares similares

Lung Beractant Increases Free Cytosolic Levels of Ca(2+) in Human Lung Fibroblasts
por: Guzmán-Silva, Alejandro, et al.
Publicado: (2015)

The Role of Pulmonary Surfactant Phospholipids in Fibrotic Lung Diseases
por: Tlatelpa-Romero, Beatriz, et al.
Publicado: (2022)

Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury
por: Valero-Jiménez, Ana, et al.
Publicado: (2018)

Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2019)

Antifibrotic Mechanism of Piceatannol in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Sheng, Hanjing, et al.
Publicado: (2022)

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023)

Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice
por: Song, Yinghua, et al.
Publicado: (2013)

Anti-Inflammatory and Antifibrotic Potential of Longidaze in Bleomycin-Induced Pulmonary Fibrosis
por: Pakhomova, Angelina, et al.
Publicado: (2023)

Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model
por: Higuchi, Tomoaki, et al.
Publicado: (2023)

Mesenchymal–Epithelial Transition in Fibroblasts of Human Normal Lungs and Interstitial Lung Diseases
por: Becerril, Carina, et al.
Publicado: (2021)

NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis
por: Li, Xiaohong, et al.
Publicado: (2018)

Anti-Inflammatory, Antioxidant, and Antifibrotic Effects of Gingival-Derived MSCs on Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Wang, Xishuai, et al.
Publicado: (2021)

Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review
por: Bos, Saskia, et al.
Publicado: (2021)

Exercise Improves Lung Inflammation, but Not Lung Remodeling and Mechanics in a Model of Bleomycin-Induced Lung Fibrosis
por: El-Mafarjeh, Elias, et al.
Publicado: (2020)

ABCA4 is an N-retinylidene-phosphatidylethanolamine and phosphatidylethanolamine importer
por: Quazi, Faraz, et al.
Publicado: (2012)

Antifibrotic therapy in idiopathic pulmonary fibrosis candidates for lung transplantation undergoing pulmonary rehabilitation
por: Pereira, Monica Pruss, et al.
Publicado: (2023)

Differences in the Evolution of Lung Function Before and After Treatment With Antifibrotics in Patients With Interstitial Lung Disease
por: Liendo-Martínez, Katiuska Herminia, et al.
Publicado: (2023)

Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
por: Mehdizadeh, Saber, et al.
Publicado: (2022)

Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts
por: Zhang, Dongwei, et al.
Publicado: (2011)

Ameliorative Potential of Donepezil with or without Prednisolone in Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of the Anti-Inflammatory, Antioxidant, and the Antifibrotic Pathways
por: Mina, Shery, et al.
Publicado: (2023)

Naftopidil reduced the proliferation of lung fibroblasts and bleomycin‐induced lung fibrosis in mice
por: Urushiyama, Hirokazu, et al.
Publicado: (2019)

Transplantation of a horseshoe kidney from a living donor: Case report, long term outcome and donor safety
por: Justo-Janeiro, Jaime Manuel, et al.
Publicado: (2015)

Antifibrotic in interstitial lung diseases: When, where, and how long?
por: Rai, Deependra K., et al.
Publicado: (2022)

Collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models
por: Shen, Zhu, et al.
Publicado: (2021)

Bleomycin: Lung toxicity: case report
Publicado: (2021)

Epithelial-fibroblast interactions in bleomycin-induced lung injury and repair.
por: Young, L, et al.
Publicado: (1993)

Corilagin Attenuates Aerosol Bleomycin-Induced Experimental Lung Injury
por: Wang, Zheng, et al.
Publicado: (2014)

Bleomycin-Induced Lung Injury After Intravenous Iron Administration
por: Saccone, Nicole, et al.
Publicado: (2022)

Nintedanib treatment for bleomycin-induced lung injury - First report
por: Rnjak, Dina, et al.
Publicado: (2023)

Erratum to collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models
Publicado: (2022)

Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Chaudhary, Sachin, et al.
Publicado: (2020)

The Role of Surgical Lung Biopsy in Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
por: Limper, Andrew H.
Publicado: (2019)

RNA Sequencing Uncovers Antifibrotic Genes during Lung Fibrosis Resolution
por: Han, Hongwei, et al.
Publicado: (2021)

The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease
por: Liang, Minrui, et al.
Publicado: (2022)

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
por: Collins, Bridget F., et al.
Publicado: (2019)

Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs
por: Guilherme, Rafael F., et al.
Publicado: (2023)

Hypoxia-Induced Epithelial-Mesenchymal Transition Is Involved in Bleomycin-Induced Lung Fibrosis
por: Guo, Liang, et al.
Publicado: (2015)

Editorial: Advances and Current Challenges in Calcium Signaling Within the Cardiovascular System
por: Berra-Romani, Roberto, et al.
Publicado: (2021)

Kinetics of lung tissue factor expression and procoagulant activity in bleomycin induced acute lung injury
por: Ma, Li, et al.
Publicado: (2015)

Inhibition of nuclear factor κB in the lungs protect bleomycin-induced lung fibrosis in mice
por: Thakur, Devaang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_80ok9b21ejd7m2tc9660qo66sv